NCT01509196View on ClinicalTrials.gov

A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

February 29, 2012

Conditions
Healthy
Interventions
DRUG

HIP0901 / Lipidilsupra

HIP0901 capsule(Fenofibric acid, 135mg) / Lipidilsupra tablet(Fenofibrate, 160mg)

Trial Locations (1)

Unknown

Korea University Anam Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01509196 - A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet | Biotech Hunter | Biotech Hunter